The Financial Comet
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

The Financial Comet

Politics

National Cancer Institute spends $218M per year on grants for ‘underrepresented’ groups: source

by admin February 24, 2025
February 24, 2025
National Cancer Institute spends $218M per year on grants for ‘underrepresented’ groups: source

A watchdog group focused on getting diversity, equity and inclusion (DEI) out of medicine found that the National Cancer Institute (NCI) is actively spending millions of grant dollars to boost the number of racial minorities in the cancer workforce. 

This funding, uncovered by the nonprofit watchdog Do No Harm, shows that $218 million in NCI grants for ‘underrepresented’ groups – mainly racial minorities – is actively dispersed by the NCI. Prior to President Donald Trump taking office, during the Biden administration, around 3% of the NCI’s total grant funding every year went to institutions so that they can hire more faculty members and scientists who are minorities, according to Do No Harm.

The revelation comes as Elon Musk’s DOGE puts a slew of funds related to DEI on the chopping block amid efforts to slim down government spending. Trump and fellow Republicans have pushed hard against DEI policies throughout the government in recent weeks, making the case that public programs should instead focus on meritocracy. 

Among the NCI’s DEI grants that remain active under Trump are two totaling more than $10.5 million, awarded to the Icahn School of Medicine at Mount Sinai. These grants support hiring initiatives aimed at ‘inclusive excellence’ and programs that promote advancing the careers of racial minorities.

One of the grant’s descriptions explicitly calls for the recruitment of 12 scientists from ‘underrepresented groups,’ while the other grant’s description includes, alongside its recruitment and hiring goals, a plan to ‘modify the Mount Sinai Health System Task Force To Address Racism Roadmap for Change with key strategies as the basis for an Icahn School of Medicine at Mount Sinai Roadmap for Inclusive Excellence.’ 

In a statement to Fox News Digital, Do No Harm Chairman Dr. Stanley Goldfarb said the NCI must ‘stop promoting a politically motivated DEI agenda.’

‘The National Cancer Institute has been taking advantage of taxpayers to push a DEI agenda on the medical field,’ Goldfarb said. ‘They dole out $218 million each year for grants prioritizing ‘underrepresented’ in medicine, which has generally been defined as anyone from a racial minority group, except Asian Americans. The National Cancer Institute should not be rewarding racial discrimination with taxpayer money. Racial discrimination has no place in medicine.’

Under former President Joe Biden, the NCI’s website was filled with statements and sources about programs tied to DEI, but, following Trump’s executive order demanding an end to DEI in the federal government, much of that has come down. Fox News Digital reached out to the NCI to question whether it had any plans to terminate any of its active grants promoting DEI hiring, but did not receive a response by press time. 

Fox News Digital also inquired about the sub-agency’s Equity Council, established in 2021 under Biden, but did not receive a response. The council is a steering committee for the NCI’s equity and inclusion efforts.

DOGE claims it has already addressed hundreds of millions of taxpayer dollars in DEI-related contract cuts, including $350 million at the Department of Education. 

Last month, DOGE announced that taxpayers would see just over $1 billion in savings through the elimination of 104 DEI contracts.

This post appeared first on FOX NEWS

previous post
Tech 5: Intel Faces M&A Rumors, Apple Debuts New iPhone
next post
Trump announces Dan Bongino will be deputy director of the FBI

Related Posts

Newly surfaced report provides more clues on COVID...

April 11, 2025

Inside Mike Johnson’s meeting with judiciary hawks over...

March 27, 2025

White House says it didn’t create a banned...

March 19, 2025

Biden aides considered ‘undemocratic’ actions to keep cognitive...

May 28, 2025

Kash Patel vows to ‘do everything’ to help...

January 31, 2025

Hamas releases 3 more hostages, including US citizen,...

February 2, 2025

Energy chief envisions US nuclear renaissance: restoring ‘pit’...

March 31, 2025

Trump says Waltz doesn’t need to apologize over...

March 26, 2025

Trump says Canada would have no tariffs as...

February 3, 2025

Supreme Court Chief Justice Roberts swoops in to...

April 10, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 2

      DeepSeek hit with large-scale cyberattack, says it’s limiting registrations

      January 28, 2025
    • 3

      Bank of America CEO says financial industry will jump into crypto payments if regulators allow it

      January 23, 2025
    • 4

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 5

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 27, 2025
    • 6

      UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

      January 27, 2025
    • 7

      Lara Trump to host weekend show on Fox News

      February 7, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: thefinancialcomet.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 thefinancialcomet.com | All Rights Reserved